| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.091 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |